Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Ralph Baric

Univ of North Carolina Chapel Hill, Department: Microbiology/immun/virology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Takeda Vaccines, Inc.

Disclosed Value
Listed Reason
Other : IP rights from awardee institution

The SFIs of the investigator are related to the funded research since the technology being used in the project has been licensed to the company with which the investigator has multiple relationships.

The Institution has determined that since the technology could be further validated as a result of the research, these financial interests could conflict with project.

Listed Research Project
PRECLINICAL ASSAYS TO PREDICT TETRAVALENT DENGUE VACCINE EFFICACY

NARRATIVE Dengue is the most significant mosquito transmitted viral infection of humans. Vaccination is a feasible solution to prevent and control dengue. Although dengue vaccines are under development, we do not know the specific properties of antibodies induced by vaccines that are likely to protect from infection. In this project investigators from the University of North Carolina and Sanofi Pasture, a leading dengue vaccine developer, will collaborate to define properties of antibodies induced by the Sanofi vaccine that correlate with protection. The main goal of the project is to develop new assays to support the current global effort to develop dengue virus vaccines.

Filed on May 08, 2018.

Tell us what you know about Ralph Baric's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Ralph Baric University of California Berkeley Conflict of Interest Takeda Vaccines Inc. $0 - $4,999
Ralph Baric Univ of North Carolina Chapel Hill Conflict of Interest Takeda Vaccines, Inc $0 - $4,999
Ralph Baric Univ of North Carolina Chapel Hill Conflict of Interest Takeda Vaccines, Inc. $0 - $4,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page